Evidence map›Paper›PMID 25303320›Full record

ArticlePloS one2014

ω-3 PUFA rich camelina oil by-products improve the systemic metabolism and spleen cell functions in fattening pigs.

Ionelia Taranu, Mihail Gras, Gina Cecilia Pistol, Monica Motiu, Daniela E Marin, Nicoleta Lefter, Mariana Ropota, Mihaela Habeanu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Genetic Improvement ofPlants (Basel, Switzerland) · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Realizing the Potential ofPlants (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ionelia TaranuINCDBNA-IBNA, National Institute of Research and development for Biology and Animal Nutrition, Balotesti, Romania.
Mihail GrasINCDBNA-IBNA, National Institute of Research and development for Biology and Animal Nutrition, Balotesti, Romania.
Gina Cecilia PistolINCDBNA-IBNA, National Institute of Research and development for Biology and Animal Nutrition, Balotesti, Romania.
Monica MotiuINCDBNA-IBNA, National Institute of Research and development for Biology and Animal Nutrition, Balotesti, Romania.
Daniela E MarinINCDBNA-IBNA, National Institute of Research and development for Biology and Animal Nutrition, Balotesti, Romania.
Nicoleta LefterINCDBNA-IBNA, National Institute of Research and development for Biology and Animal Nutrition, Balotesti, Romania.
Mariana RopotaINCDBNA-IBNA, National Institute of Research and development for Biology and Animal Nutrition, Balotesti, Romania.
Mihaela HabeanuINCDBNA-IBNA, National Institute of Research and development for Biology and Animal Nutrition, Balotesti, Romania.
National Research Development Institute for Animal Biology and Nutrition · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Camelina oil-cakes results after the extraction of oil from Camelina sativa plant. In this study, camelina oil-cakes were fed to fattening pigs for 33 days and its effect on performance, plasma biochemical analytes, pro-/anti-inflammatory mediators and antioxidant detoxifying defence in spleen was investigated in comparison with sunflower meal. 24 crossbred TOPIG pigs were randomly assigned to one of two experimental dietary treatments containing either 12% sunflower meal (treatment 1-T1), or 12.0% camelina oil-cakes, rich in polyunsaturated fatty acids ω-3 (ω-3 PUFA) (treatment 2-T2). The results showed no effect of T2 diet (camelina cakes) on feed intake, average weight gain or feed efficiency. Consumption of camelina diet resulted in a significant decrease in plasma glucose concentration (18.47%) with a trend towards also a decrease of plasma cholesterol. In spleen, T2 diet modulated cellular immune response by decreasing the protein and gene expression of pro-inflammatory markers, interleukin 1-beta (IL-1β), tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6) and interleukin (IL-8) and cyclooxigenase 2 (COX-2) in comparison with T1 diet. By contrast, T2 diet increased (P<0.05) in spleen the mRNA expression of antioxidant enzymes, catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase 1 (GPx1) by 3.43, 2.47 and 1.83 fold change respectively, inducible nitric oxide synthase (iNOS) (4.60 fold), endothelial nitric oxide synthase (eNOS) (3.23 fold) and the total antioxidant level (9.02%) in plasma. Camelina diet increased also peroxisome-proliferator activated receptor gamma (PPAR-γ) mRNA and decreased that of mitogen-activated protein kinase 14 (p38α MAPK) and nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB). At this level of inclusion (12%) camelina oil-cakes appears to be a potentially alternative feed source for pig which preserves a high content of ω-3 PUFA indicating antioxidant properties by the stimulation of detoxifying enzymes expression and the suppression of spleen pro-inflammatory markers.

Indexed as

Animal FeedAnimalsAntioxidantsBiomarkersBlood Chemical AnalysisCamelliaFatty Acids, Omega-3Gene ExpressionGene Expression ProfilingImmunoglobulinsInflammation MediatorsMitogen-Activated Protein Kinase 14NF-kappa BNitric OxidePlant OilsPPAR gammaAntioxidantsBiomarkersFatty Acids, Omega-3ImmunoglobulinsInflammation MediatorsMitogen-Activated Protein Kinase 14NF-kappa BNitric OxidePlant OilsPPAR gamma

Identifiers

PMID25303320
PMCPMC4193896
OpenAlexW2134121740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.